Literature DB >> 9770154

Cryptosporidiosis in patients with AIDS: correlates of disease and survival.

Y C Manabe1, D P Clark, R D Moore, J A Lumadue, H R Dahlman, P C Belitsos, R E Chaisson, C L Sears.   

Abstract

Although 10%-15% of patients with AIDS in the United States may acquire cryptosporidium infection, little data exist on clinical or histological characteristics that differentiate clinical outcomes. A case-control study of 83 HIV-positive adult patients with cryptosporidiosis was conducted, as was a histopathologic review of data on gastrointestinal biopsy specimens from 30 patients. Four clinical syndromes were identified: chronic diarrhea (36% of patients), choleralike disease (33%), transient diarrhea (15%), and relapsing illness (15%). A multivariate analysis of data for cases and controls revealed that acquiring cryptosporidiosis was associated with the presence of candidal esophagitis (odds ratio [OR], 2.53; P < .002) and Caucasian race (OR, 6.71; P = .0001) but not with sexual orientation. Cases had a significantly shorter duration of survival from the time of diagnosis than did controls (240 vs. 666 days, respectively; P = .0004), which was independent of sex, race, or or injection drug use. Antiretroviral use was protective against disease (OR, 0.072; P = .0001). All four clinical syndromes were represented among the histological data. There was no statistically significant correlation between histological intensity of infection and clinical severity of illness.

Entities:  

Mesh:

Year:  1998        PMID: 9770154     DOI: 10.1086/514701

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

1.  Human intestinal and biliary cryptosporidiosis.

Authors:  Xian-Ming Chen; Nicholas F LaRusso
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

2.  The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism.

Authors:  Steven P O'Hara; Aaron J Small; Jeremy B Nelson; Andrew D Badley; Xian-Ming Chen; Gregory J Gores; Nicholas F Larusso
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

Review 3.  Intestinal immune response to human Cryptosporidium sp. infection.

Authors:  Birte Pantenburg; Sara M Dann; Heuy-Ching Wang; Prema Robinson; Alejandro Castellanos-Gonzalez; Dorothy E Lewis; A Clinton White
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

4.  Human CD8(+) T cells clear Cryptosporidium parvum from infected intestinal epithelial cells.

Authors:  Birte Pantenburg; Alejandro Castellanos-Gonzalez; Sara M Dann; Rhykka L Connelly; Dorothy E Lewis; Honorine D Ward; A Clinton White
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

5.  Generating and Maintaining Transgenic Cryptosporidium parvum Parasites.

Authors:  Mattie C Pawlowic; Sumiti Vinayak; Adam Sateriale; Carrie F Brooks; Boris Striepen
Journal:  Curr Protoc Microbiol       Date:  2017-08-11

Review 6.  Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans.

Authors:  R J Kothavade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

7.  High levels of CXCL10 are produced by intestinal epithelial cells in AIDS patients with active cryptosporidiosis but not after reconstitution of immunity.

Authors:  Heuy-Ching Wang; Sara M Dann; Pablo C Okhuysen; Dorothy E Lewis; Cynthia L Chappell; Douglas G Adler; A Clinton White
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

8.  Induction of Inflammatory Responses in Splenocytes by Exosomes Released from Intestinal Epithelial Cells following Cryptosporidium parvum Infection.

Authors:  Yang Wang; Yujuan Shen; Hua Liu; Jianhai Yin; Xin-Tian Zhang; Ai-Yu Gong; Xiqiang Chen; Siyi Chen; Nicholas W Mathy; Jianping Cao; Xian-Ming Chen
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

9.  The Serologic response to Cryptosporidium in HIV-infected persons: implications for epidemiologic research.

Authors:  J N Eisenberg; J W Priest; P J Lammie; J M Colford
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

10.  Charting the proteome of Cryptosporidium parvum sporozoites using sequence similarity-based BLAST searching.

Authors:  A M A M Z Siddiki; Jonathan M Wastling
Journal:  J Vet Sci       Date:  2009-09       Impact factor: 1.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.